Lerman RD, Cannom DS
Good Samaritan Hospital, Department of Cardiology, 1225 Wilshire Boulevard, Los Angeles, CA 90017, USA.
Curr Treat Options Cardiovasc Med. 1999 Jun;1(1):91-96. doi: 10.1007/s11936-999-0011-y.
Survivors of an episode of out-of-hospital ventricular fibrillation (not due to a reversible cause) or hemodynamically significant sustained ventricular tachycardia should in most cases receive an implantable cardioverter defibrillator (ICD) rather than antiarrhythmic drug therapy. A number of recently published clinical trials (summarized later) point to improved survival with ICD implantation. It is also important to identify the cause of the ventricular rhythm and to treat adequately the underlying cardiomyopathy with the appropriate angiotensin-converting enzyme (ACE) inhibitors, beta-blockers, and aspirin. The role of electrophysiologic study is a matter of debate, and it is used less commonly than it was a decade ago.
院外心室颤动（非由可逆性病因引起）或血流动力学显著的持续性室性心动过速发作的幸存者，在大多数情况下应接受植入式心脏复律除颤器（ICD）治疗，而非抗心律失常药物治疗。近期发表的多项临床试验（稍后总结）表明，植入ICD可提高生存率。识别室性心律失常的病因，并使用适当的血管紧张素转换酶（ACE）抑制剂、β受体阻滞剂和阿司匹林充分治疗潜在的心肌病也很重要。电生理检查的作用存在争议，其使用频率比十年前低。
